Related Experiment Video

Updated: Jun 12, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Allogeneic stem cell transplantation for acute myeloid leukemia

Jacopo Peccatori, Fabio Ciceri

    Haematologica
    |June 2, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
    03:40

    Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

    Published on: December 8, 2023

    Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
    10:02

    Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

    Published on: January 6, 2023

    Related Experiment Videos

    Last Updated: Jun 12, 2026

    Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
    11:55

    Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

    Published on: March 14, 2011

    Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
    03:40

    Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

    Published on: December 8, 2023

    Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
    10:02

    Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

    Published on: January 6, 2023

    Related Concept Videos

    Bone Marrow Sampling and Transplants01:22

    Bone Marrow Sampling and Transplants

    Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
    The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
    Stem Cell Therapy for Tissue Regeneration01:21

    Stem Cell Therapy for Tissue Regeneration

    Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
    Types of Stem Cells used in Stem Cell Therapy
    The two main cell types that...

    Articles linked to this work by shared authors, journal, and citation graph.

    Impact of gemtuzumab ozogamicin consolidation on hematopoietic stem cells (HSCs) mobilization in AML: analysis of 20 patients.

    Annals of hematology·2023

    GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT.

    Journal of hematology & oncology·2023

    Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia.

    Frontiers in oncology·2023

    Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT.

    HemaSphere·2023

    Imaging biomarkers of leukaemic choroidopathy.

    Acta ophthalmologica·2023

    Mesoangioblasts at 20: From the embryonic aorta to the patient bed.

    Frontiers in genetics·2023

    Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.

    Haematologica·2026

    Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial"

    Haematologica·2026

    Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia".

    Haematologica·2026

    Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".

    Haematologica·2026

    Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.

    Haematologica·2026

    Defining the therapeutic window of NLRP6 modulation in graft-versus-host disease. Comment on: "NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway".

    Haematologica·2026

    Intercostal nerve block with liposomal bupivacaine versus no regional analgesia after uniportal thoracoscopic surgery: A randomized controlled trial.

    JTCVS open·2026

    Changes and predictors of symptoms in unrelated hematopoietic stem cell donors: A longitudinal study.

    Journal of psychosomatic research·2026

    Type-II-CD20-targeted therapy for CD38 antibody-refractory antibody-mediated rejection after kidney transplantation: a case report.

    Frontiers in immunology·2026

    Donor-derived cell-free DNA testing for noninvasive monitoring of allograft rejection after lung transplantation.

    Frontiers in immunology·2026

    Alemtuzumab Induction via Intravenous vs. Subcutaneous Administration in Pediatric Kidney Transplantation.

    Pediatric transplantation·2026

    CD4- and CD8-to-Total Lymphocyte Ratios to Guide Rabbit Anti-Thymocyte Globulin Induction in Kidney Transplant Recipients: A Single-Center Feasibility Study.

    Nephrology (Carlton, Vic.)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us